Withdrawal of fingolimod treatment for relapsing–remitting multiple sclerosis: report of six cases
Multiple Sclerosis Journal, 08/02/2012
Hakiki B et al. – The findings suggest that clinical and magnetic resonance (MR) outcomes after fingolimod suspension can vary among patients. Systematic collection of clinical, laboratory and imaging data is highly advisable to identify subjects who are at higher risk of rebound and to define effective management strategies in these subjects.